Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8818070 | Health Policy | 2017 | 8 Pages |
Abstract
Although this study provides useful insights in the possibilities for improving RE-models for persistently high-cost individuals, improving compensation remains challenging and dependent on the ongoing debate regarding coverage and reimbursement of expensive drugs.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Frank Eijkenaar, René C.J.A. van Vliet,